Abstract:Type I interferons (IFNα/β) regulate diverse aspects of host defense, but their impact on hematopoietic stem and progenitor cells (HSC/HSPCs) during infection remains unclear. Hematologic impairment can occur in severe infections, thus we sought to investigate the impact of type I IFNs on hematopoiesis in a tick-borne infection with a virulent ehrlichial pathogen that causes shock-like disease. During infection, IFNα/β induced severe bone marrow (BM) loss, blunted infection-induced emergency myelopoiesis, and reduced phenotypic HSPCs and HSCs. In the absence of type I IFN signaling, BM and splenic hematopoiesis were increased, and HSCs derived from Ifnar1-deficient mice were functionally superior in competitive BM transplants. Type I IFNs impaired hematopoiesis during infection by both limiting HSC/HSPC proliferation and increasing HSPC death. Using mixed BM chimeras we determined that type I IFNs restricted proliferation indirectly, whereas HSPC death occurred via direct IFNαR -mediated signaling. IFNαR-dependent signals resulted in reduced caspase 8 expression and activity, and reduced cleavage of RIPK1 and RIPK3, relative to Ifnar1-deficient mice. RIPK1 antagonism with Necrostatin-1s rescued HSPC and HSC numbers during infection. Early antibiotic treatment is required for mouse survival, however antibiotic-treated survivors had severely reduced HSPCs and HSCs. Combination therapy with antibiotics and Necrostatin-1s improved HSPC and HSC numbers in surviving mice, compared to antibiotic treatment alone. We reveal two mechanisms whereby type I IFNs drive hematopoietic collapse during severe infection: direct sensitization of HSPCs to undergo cell death and enhanced HSC quiescence. Our studies reveal a strategy to ameliorate the type I IFN-dependent loss of HSCs and HSPCs during infection, which may be relevant to other infections wherein type I IFNs cause hematopoietic dysfunction.

Type I interferon governs immunometabolic checkpoints that coordinate inflammation during infection

Type I interferon governs immunometabolic checkpoints that coordinate inflammation during Staphylococcal infection

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

Noncanonical NF-κB Pathway Controls the Production of Type I Interferons in Antiviral Innate Immunity

Metabolic regulation of type I interferon production

Type I IFNs facilitate innate immune control of the opportunistic bacteria Burkholderia cenocepacia in the macrophage cytosol

Macrophages control pathological interferon responses during viral respiratory infection.

Interferon α and β induce differential transcriptional and functional metabolic phenotypes in human macrophages and blunt glycolysis in response to antigenic stimuli

Type I interferon regulates interleukin-1beta and IL-18 production and secretion in human macrophages

Type I interferon signaling and peroxisomal dysfunction contribute to enhanced inflammatory cytokine production in Irgm1-deficient macrophages

Interferon-γ Regulates Cellular Metabolism and Mrna Translation to Potentiate Macrophage Activation

Type 1 Interferons Induce Changes in Core Metabolism That Are Critical for Immune Function

Type I interferons in infectious disease

Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils

Interferon target-gene expression and epigenomic signatures in health and disease

Crosstalk Between Autophagy and the cGAS–STING Signaling Pathway in Type I Interferon Production

Type I Interferons and Il-12: Convergence and Cross Regulation among Mediators of Cellular Immunity.

Interferon-sensitized hematopoietic progenitors dynamically alter organismal immunity

Type I IFNs Drive Hematopoietic Stem and Progenitor Cell Collapse Via Impaired Proliferation and Increased RIPK1-dependent Cell Death During Shock-Like Ehrlichial Infection.

Cell-intrinsic regulation of phagocyte function by interferon lambda during pulmonary viral, bacterial super-infection

Regulation of Interferon and Toll‐like Receptor Signaling During Macrophage Activation by Opposing Feedforward and Feedback Inhibition Mechanisms